JP2010513292A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513292A5
JP2010513292A5 JP2009541454A JP2009541454A JP2010513292A5 JP 2010513292 A5 JP2010513292 A5 JP 2010513292A5 JP 2009541454 A JP2009541454 A JP 2009541454A JP 2009541454 A JP2009541454 A JP 2009541454A JP 2010513292 A5 JP2010513292 A5 JP 2010513292A5
Authority
JP
Japan
Prior art keywords
phenyl
methoxy
chloro
thiazolo
azetidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009541454A
Other languages
English (en)
Japanese (ja)
Other versions
JP5269804B2 (ja
JP2010513292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/084812 external-priority patent/WO2008076562A1/en
Publication of JP2010513292A publication Critical patent/JP2010513292A/ja
Publication of JP2010513292A5 publication Critical patent/JP2010513292A5/ja
Application granted granted Critical
Publication of JP5269804B2 publication Critical patent/JP5269804B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009541454A 2006-12-14 2007-11-15 新規なmch受容体拮抗薬 Expired - Fee Related JP5269804B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87001106P 2006-12-14 2006-12-14
US60/870,011 2006-12-14
PCT/US2007/084812 WO2008076562A1 (en) 2006-12-14 2007-11-15 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists

Publications (3)

Publication Number Publication Date
JP2010513292A JP2010513292A (ja) 2010-04-30
JP2010513292A5 true JP2010513292A5 (cg-RX-API-DMAC7.html) 2010-11-25
JP5269804B2 JP5269804B2 (ja) 2013-08-21

Family

ID=39204735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541454A Expired - Fee Related JP5269804B2 (ja) 2006-12-14 2007-11-15 新規なmch受容体拮抗薬

Country Status (16)

Country Link
US (1) US8049013B2 (cg-RX-API-DMAC7.html)
EP (1) EP2089397B1 (cg-RX-API-DMAC7.html)
JP (1) JP5269804B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090082484A (cg-RX-API-DMAC7.html)
CN (1) CN101558075A (cg-RX-API-DMAC7.html)
AR (1) AR064127A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007334171A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0721086A2 (cg-RX-API-DMAC7.html)
CA (1) CA2671765A1 (cg-RX-API-DMAC7.html)
CL (1) CL2007003480A1 (cg-RX-API-DMAC7.html)
EA (1) EA015559B1 (cg-RX-API-DMAC7.html)
ES (1) ES2392276T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009006319A (cg-RX-API-DMAC7.html)
PE (1) PE20081572A1 (cg-RX-API-DMAC7.html)
TW (1) TW200831082A (cg-RX-API-DMAC7.html)
WO (1) WO2008076562A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
SA110310332B1 (ar) 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
AU2010332819B2 (en) 2009-12-18 2014-02-27 Janssen Pharmaceutica Nv Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
EP2513117B1 (en) 2009-12-18 2013-08-28 Janssen Pharmaceutica, N.V. Bicyclic thiazoles as allosteric modulators of mglur5 receptors
EA201291384A1 (ru) * 2010-07-06 2013-07-30 Астразенека Аб Терапевтические агенты 976
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014115801A1 (ja) * 2013-01-25 2014-07-31 セントラル硝子株式会社 α,α-ジフルオロアセトアルデヒドの製造方法
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
CN116082225A (zh) * 2016-08-08 2023-05-09 北京康蒂尼药业股份有限公司 一种羟尼酮的制备方法
CN107698498A (zh) * 2016-08-08 2018-02-16 罗楹 一种羟尼酮的制备方法
CN108997138A (zh) * 2018-08-17 2018-12-14 济南和润化工科技有限公司 一种无溶剂催化氢化法生产对氟苯胺的方法
US20260152484A1 (en) * 2021-11-09 2026-06-04 Vigil Neuroscience, Inc. Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
ATE446962T1 (de) * 2004-12-17 2009-11-15 Lilly Co Eli Thiazolopyridinon-derivate als mch- rezeptorantagonisten

Similar Documents

Publication Publication Date Title
JP2008539267A5 (cg-RX-API-DMAC7.html)
JP2009539875A5 (cg-RX-API-DMAC7.html)
JP2010500293A5 (cg-RX-API-DMAC7.html)
JP2014530900A5 (cg-RX-API-DMAC7.html)
JP2009529541A5 (cg-RX-API-DMAC7.html)
JP2012502927A5 (cg-RX-API-DMAC7.html)
JP2015524450A5 (cg-RX-API-DMAC7.html)
JP2013519680A5 (cg-RX-API-DMAC7.html)
JP2010513435A5 (cg-RX-API-DMAC7.html)
JP2013510123A5 (cg-RX-API-DMAC7.html)
JP2010535252A5 (cg-RX-API-DMAC7.html)
JP2008519794A5 (cg-RX-API-DMAC7.html)
CA2679530A1 (en) Benzimidazole compound and pharmaceutical use thereof
JP2006503845A5 (cg-RX-API-DMAC7.html)
JP2016514117A5 (cg-RX-API-DMAC7.html)
JP2017526724A5 (cg-RX-API-DMAC7.html)
AR064127A1 (es) Compuesto de tiazolopiridinona, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento
JP2014518212A5 (ja) 化合物及び組成物
JP2010502576A5 (cg-RX-API-DMAC7.html)
JP2009501745A5 (cg-RX-API-DMAC7.html)
JP2005500370A5 (cg-RX-API-DMAC7.html)
CN101198323A (zh) 用于治疗或预防精神障碍的治疗组合
HRP20160128T1 (hr) Terapeutska sredstva 713
AR088087A1 (es) Inhibidores de la monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y trastornos relacionados
JP2013544794A5 (cg-RX-API-DMAC7.html)